Acerta Pharma BV
General
Total Cases11
Active Cases1
Patents22
--
--
--
Ratings
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/17/25 | WAIVER OF SERVICE returned executed by AstraZeneca UK Limited, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca AB: For MSN Pharmaceuticals Inc. waiver sent on 1/13/2025, answer due 3/14/2025. (Joyce, Alexandra) (Entered: 01/17/2025) | |
| 01/17/25 | WAIVER OF SERVICE returned executed by AstraZeneca UK Limited, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca AB: For MSN Laboratories Pvt. Ltd. waiver sent on 1/13/2025, answer due 3/14/2025. (Joyce, Alexandra) (Entered: 01/17/2025) | |
| 01/15/25 | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 01/15/2025) | |
| 01/10/25 | Summons Issued as to MSN Laboratories Pvt. Ltd. on 1/10/2025; MSN Pharmaceuticals Inc. on 1/10/2025. (Attachments: # [1] Summons Issued)(oam) (Entered: 01/10/2025) | |
| 01/10/25 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited filed by AstraZeneca AB, Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP. (oam) (Entered: 01/10/2025) | |
| 01/10/25 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083; 11,059,829. (oam) (Entered: 01/10/2025) | |
| 01/10/25 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/27/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/27/2027. (oam) (Entered: 01/10/2025) | |
| 01/10/25 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 01/10/2025) | |
| 01/10/25 | COMPLAINT against MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. (Filing fee $ 405, receipt number ADEDC-4587378) - filed by AstraZeneca UK Limited, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca AB. (Attachments: # [1] Exhibits A-B, # [2] Civil Cover Sheet)(oam) (Entered: 01/10/2025) | |
| 07/15/24 | Report to the Commissioner of Patents and Trademarks. (lnb) (Entered: 07/15/2024) |